Back

Management of heterozygous familial hypercholesterolemia in a statin-intolerant, inclisiran non-responder patient

29 August 2026 (13:59 - 14:15)
Organised by: Logo
Congress Presentation Part of: Guideline management of dyslipidaemia: cases in context Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Despo Melanarkiti

Paphos General Hospital, Paphos (Cyprus)

4 More presentations in this session

Presentation thumbnail
Guideline management of dyslipidaemia: cases in context - get ready for the session
Professor C. Chen (Houston, US)
Slides Video
Presentation thumbnail
Dual atherogenic burden from familial hypercholesterolaemia and elevated lipoprotein(a) manifesting as triple-vessel coronary disease at 24 years of age
Doctor J. Atencio (Panama, PA)
Slides Video
Presentation thumbnail
When youth meets end-stage disease: a 20-year-old female with homozygous familial hypercholesterolaemia and premature atherosclerotic disease.
Doctor K. Bautista Hernandez (Mexico City, MX)
Slides Video
Presentation thumbnail
Strategy for dyslipidaemia management in an elderly patient with polyvascular atherosclerosis and extreme cardiovascular risk
Professor O. Yepanchintseva (Kiev, UA)
Slides Video

Access the full session

Session thumbnail
Guideline management of dyslipidaemia: cases in context
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 13:59 CET
You may be interested in
thumbnail
Congress Presentation
From evolocumab to inclisiran: an unexpected surprise in a patient at high cardiovascular risk
11 May 2026
thumbnail
Congress Presentation
Familial hypercholesterolemia and its complex vascular manifestations: from atherosclerosis to arterial ectasia
11 December 2025
thumbnail
Congress Presentation
Precisely identifying sitosterolaemia via genetic testing with whole exome sequencing: a young male misdiagnosed with familial hypercholesterolaemia
29 August 2025
thumbnail
Congress Presentation
Case 1 - a Cypriot patient with a challenging familial hypercholesterolaemia management
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources